Current concepts on the pathogenesis of systemic sclerosis
ME Truchetet, NC Brembilla, C Chizzolini - Clinical reviews in allergy & …, 2023 - Springer
From the clinical standpoint, systemic sclerosis (SSc) is characterized by skin and internal
organ fibrosis, diffuse fibroproliferative vascular modifications, and autoimmunity. Clinical …
organ fibrosis, diffuse fibroproliferative vascular modifications, and autoimmunity. Clinical …
Pathophysiology of systemic sclerosis: current understanding and new insights
ABSTRACT Introduction: Systemic sclerosis (SSc) is a complex autoimmune connective
tissue disease characterized by chronic and progressive tissue and organ fibrosis with …
tissue disease characterized by chronic and progressive tissue and organ fibrosis with …
The pathogenesis of systemic sclerosis revisited
M Geyer, U Müller-Ladner - Clinical reviews in allergy & immunology, 2011 - Springer
Although infectiological stimuli, environmental factors and genotypic features are known to
contribute to the initiation and perpetuation of systemic sclerosis (SSc), its etiology still …
contribute to the initiation and perpetuation of systemic sclerosis (SSc), its etiology still …
Systemic sclerosis: current views of its pathogenesis
CT Derk, SA Jimenez - Autoimmunity reviews, 2003 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disorder of unknown etiology characterized by
severe and often progressive cutaneous and visceral fibrosis, pronounced alterations in the …
severe and often progressive cutaneous and visceral fibrosis, pronounced alterations in the …
Pathogenesis of systemic sclerosis
D Pattanaik, M Brown, BC Postlethwaite… - Frontiers in …, 2015 - frontiersin.org
Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases. It
targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts …
targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts …
Systemic sclerosis: from pathophysiology to novel therapeutic approaches
D Benfaremo, S Svegliati, C Paolini, S Agarbati… - Biomedicines, 2022 - mdpi.com
Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by
small vessel alterations and progressive fibrosis of the skin and internal organs. The …
small vessel alterations and progressive fibrosis of the skin and internal organs. The …
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
J Varga, M Trojanowska… - Journal of Scleroderma …, 2017 - journals.sagepub.com
Systemic sclerosis (SSc) is a complex disease characterized by early microvascular
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment
AJ Affandi, TRDJ Radstake, W Marut - Seminars in immunopathology, 2015 - Springer
Systemic sclerosis (SSc) is a complex autoimmune disease in which immune activation,
vasculopathy, and extensive fibrosis of the skin and internal organs are among the principal …
vasculopathy, and extensive fibrosis of the skin and internal organs are among the principal …
The immunopathogenesis of fibrosis in systemic sclerosis
M Brown, S O'Reilly - Clinical & Experimental Immunology, 2019 - academic.oup.com
Systemic sclerosis (SSc) is an idiopathic systemic autoimmune disease. It is characterized
by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction …
by a triad of hallmarks: immune dysfunction, fibrosis and vasculopathy. Immune dysfunction …
The pathogenesis of systemic sclerosis
TR Katsumoto, ML Whitfield… - Annual Review of …, 2011 - annualreviews.org
Systemic sclerosis (SSc), also known as scleroderma, is a rare connective tissue disease
characterized by vascular and immune dysfunction, leading to fibrosis that can damage …
characterized by vascular and immune dysfunction, leading to fibrosis that can damage …